Tuberculosis and COPD
Tuberculosis and Chronic Obstructive Pulmonary Disease carry about a significant concern in terms of morbidity and mortality around the world. This spotlight on various parts of tuberculosis as far as the association with COPD such as in the advancement of chronic airflow obstruction as a sequel of active tuberculosis and assessing the key role of cigarette smoking in the pathogenesis of both conditions. Patients determined to have tuberculosis may regularly have extensive co-morbidity such as COPD and the impact of an underlying diagnosis of COPD on results in tuberculosis is also reviewed. COPD Conferences explores the new ideas and techniques of pulmonary therapy.
- Airway obstruction
- Genetic Vulnerability
- Common Risk factors
- Co-Morbidity on TB mortality
Related Conference of Tuberculosis and COPD
14th International Conference on COPD Clinical Trials & Lung Care Advances
18th International Conference on Chronic Obstructive Pulmonary Disease
16th International Conference on Pulmonary & Respiratory Medicine
Tuberculosis and COPD Conference Speakers
Recommended Sessions
- Asthma and COPD
- Case Report
- Chronic Obstructive Pulmonary Disease
- COPD and Cardiovascular Diseases
- COPD Complications
- COPD Exacerbations
- COPD Therapeutics
- Depression and anxiety in COPD
- Drug Discovery of COPD
- Epidemiology of COPD
- Genetic risk factor of COPD
- Lung Cancer
- Pathophysiology of COPD
- Pediatric Pulmonary, Critical care and Sleep
- Pneumonia and COPD
- Pulmonary diseases-treatment and therapies
- Pulmonary Hypertension
- Pulmonary Rehabilitation
- Self-Management and Prevention of COPD
- Tuberculosis and COPD
Related Journals
Are you interested in
- Advanced Lung Imaging - PULMONOLOGY 2026 (France)
- AI in Pulmonary Diagnostics - PULMONOLOGY 2026 (France)
- Asthama - Copd 2026 (France)
- Chronic Bronchitis - Copd 2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Copd 2026 (France)
- COPD Innovations - PULMONOLOGY 2026 (France)
- Coronavirus (COVID-19) - Copd 2026 (France)
- Critical Care Pulmonology - PULMONOLOGY 2026 (France)
- Cystic Fibrosis - Copd 2026 (France)
- Digital Respiratory Health - PULMONOLOGY 2026 (France)
- Emphysema - Copd 2026 (France)
- Environmental Lung Diseases - PULMONOLOGY 2026 (France)
- Interstitial Lung Diseases - PULMONOLOGY 2026 (France)
- Interventional pulmonology - Copd 2026 (France)
- Interventional Pulmonology - PULMONOLOGY 2026 (France)
- Lung Cancer - Copd 2026 (France)
- Lung Cancer Biomarkers - PULMONOLOGY 2026 (France)
- Mechanical Ventilation Strategies - PULMONOLOGY 2026 (France)
- Pediatric Pulmonology - PULMONOLOGY 2026 (France)
- Pneumonia - Copd 2026 (France)
- Precision Respiratory Medicine - PULMONOLOGY 2026 (France)
- Pulmonary Arterial Hypertension - Copd 2026 (France)
- Pulmonary Fibrosis Research - PULMONOLOGY 2026 (France)
- Pulmonary Hypertension - PULMONOLOGY 2026 (France)
- Pulmonary Rehabilitation - PULMONOLOGY 2026 (France)
- Respiratory Drug Delivery - PULMONOLOGY 2026 (France)
- Respiratory Infections - PULMONOLOGY 2026 (France)
- Respiratory Tract Infections - Copd 2026 (France)
- Severe Asthma Therapies - PULMONOLOGY 2026 (France)
- Sleep & Breathing Disorders - PULMONOLOGY 2026 (France)
- Stages & Severity on Lung Diseases - Copd 2026 (France)
- Thoracic Surgery Advances - PULMONOLOGY 2026 (France)
